Recombinant dna expression vectors and dna compounds that encode isopenicillin n synthetase from penicillium chrysogenum
CA 1309675 C · Owner: Carr, Lucinda Gayle · Inventors: Queener, Stephen Wyatt; Carr, Lucinda Gayle; Ingolia, Thomas Dominick
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
X-6932, Abstract, The present invention comprises novel DNA compounds that encode isopenicillin N synthetase. The invention also comprises methods, transformants and, polypeptides related to the novel DNA compounds. The novel isopenicillin N synthetase-encoding DNA together, with its associated transcription and translation activating sequence, was isolated from Penicillium chrysogenum. The isopenicillin N synthetase-encoding DNA can be used to construct novel E. coli expression vectors that drive expression of isopenicillin N synthetase in E. coli. The intact P. chrysogenum isopenicillin N synthetase-encoding DNA and associated transcription and translation activating sequence can also be …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted November 3, 1992. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended November 3, 2009.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.